TECHNOLOGY

OLYS Pharma’s research targets mechanisms of action to treat and prevent neurogenic inflammation of the Neuro-Immuno-Cutaneous-Endocrine (NICE) system. There are different types of stress (metabolic, osmotic, chemical, traumatic, emotional, etc.) that can deregulate the NICE system and lead to neurogenic inflammation and cause painful chronic inflammatory pathologies.

OLYS Pharma’s approach is unique. It aims simultaneously to obtain corrective physiological responses and restore cellular homeostasis, thanks to combined effects, namely:

  • correct neurotransmission dysfunctions,
  • inhibit the pro-inflammatory process,
  • modulate the immunological, endocrine and paracrine responses,
  • improve cell metabolism, block the pathways of apoptosis,
  • block the degeneration of the epidermal nerves, restore their myelination and stimulate the neo-growth of axons and dendrites.

NEUROGENIC INFLAMMATION:

AT THE HEART OF PATHOLOGIES

Neurogenic inflammation

> Peripheral neuropathic pain

> Trigeminocervical complex pain – Migraine

> Low back pain

> Sciatica pain

> Rheumatoid arthritis pain